Navigation Links
Astellas Announces Vice President of Sales and Marketing for U.S. Oncology Franchise
Date:5/19/2011

DEERFIELD, Ill., May 19, 2011 /PRNewswire/ -- Astellas Pharma US, Inc. ("Astellas") recently hired Mark Reisenauer as vice president of sales and marketing, oncology. Reporting directly to Patrick Shea, senior vice president of marketing & sales, Reisenauer will be responsible for all U.S. commercial activities supporting marketed products, the company's oncology co-promotion partners and will lead commercial planning for early stage development compounds.

"Astellas has made significant progress over the last year toward becoming a global category leader in oncology with the integration of OSI oncology and further development of the pipeline. Mark's breadth of product experience, along with his proven leadership capabilities, will be instrumental in Astellas' future success in oncology," said Shea. "We are excited to add Mark to our management team."

The majority of Mark's 20-plus year career has been committed to oncology therapies, where he has had sales and marketing responsibilities in a variety of capacities (domestic and global) at Abbott, Pharmacia, Bristol-Myers Squibb and Zeneca. Most recently, Mark has served as senior vice president and chief commercial officer of Micromet Inc. where he was involved in investor and public relations, clinical strategy, business development, and commercial launch planning.

About Astellas

Astellas Pharma US, Inc., located in Deerfield, Illinois, is a U.S. affiliate of Tokyo-based Astellas Pharma Inc. Astellas is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. The organization is committed to becoming a global category leader in focused areas by combining outstanding R&D and marketing capabilities. In the U.S., Astellas markets products in the areas of Anti-Infectives, Cardiology, Dermatology, Neuroscience, Transplant, Oncology and Urology. For more information about Ast
'/>"/>

SOURCE Astellas Pharma US, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Optimer Pharmaceuticals and Astellas Announce Collaboration to Commercialize Fidaxomicin for Clostridium difficile infection (CDI) in Europe and Certain Other Countries in Middle East, Africa and CIS
2. Astellas to Review Strategic Business Alternatives for Prosidion Subsidiary
3. Reportlinker Adds Astellas Pharma Inc.: PharmaVitae Profile
4. Astellas Announces Retirement of Donald Rice and Appointment of Sef Kurstjens as CEO and President of Agensys, Inc.
5. Although NeurogesX/Astellass Qutenza is Only Approved for Postherpetic Neuralgia, Surveyed U.S. Physicians are Likely to Prescribe It for All Neuropathic Pain Types
6. Astellas Mobilizes 1,300+ Employees in the Americas to Participate in First Annual Changing Tomorrow Day
7. Astellas Awards Scholarships to 12 Transplant Recipients and Donors Who Embody Hope, Courage and Achievement
8. Agensys, an Affiliate of Astellas, Announces Initiation of Phase I Clinical Trial of AGS-16M8F for Renal Cancer
9. Astellas Announces Successful Completion of Initial Tender Offer for Shares of OSI and Announces Subsequent Offer Period
10. Astellas Announces Full Slate of Independent Director Nominees for Election at OSI Pharmaceuticals 2010 Annual Stockholders Meeting
11. Ambit Biosciences and Astellas Enter Strategic Partnership to Research, Develop and Commercialize FLT3 Kinase Inhibitors in Multiple Indications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2015)... 2015  The Physician-Patient Alliance for Health & ... RRT has joined the Physician-Patient Alliance Board of ... Registered Respiratory Therapist who has practiced in the post-acute ... his excellent work on critical patient safety issues. He ... (AARC) at various conferences addressing the need for ...
(Date:4/28/2015)... , April 28, 2015 ... to around $3,876.3 million by 2019, growing at a ... Browse through the TOC of the pharmacy information systems ... provided. This also provides a glimpse of the segmentation ... and is supported by various tables and figures. ...
(Date:4/28/2015)... PORTLAND, Ore. , April 28, 2015 ... medical risk assessment company that develops, manufactures and markets ... and evaluating chronic diseases, today announced that it has ... 15 insurance plans in the country who offer Medicare ... of the top 15 insurance plans who are now ...
Breaking Medicine Technology:Noted Respiratory Therapist and AARC Representative Gene Gantt Joins Physician-Patient Alliance for Health & Safety Advisory Board 2Pharmacy Information Systems Market is Expected to Reach $3,876.3 Million by 2019, at a CAGR of 7.7% From 2014 to 2019 2Pharmacy Information Systems Market is Expected to Reach $3,876.3 Million by 2019, at a CAGR of 7.7% From 2014 to 2019 3Semler Adds Top Insurance Plan to Customer List 2Semler Adds Top Insurance Plan to Customer List 3
... 10 Jefferson Radiology has acquired two Medical ... medical epicenter in north central Connecticut, and in ... expertise available at nine outpatient locations in the ... services at Hartford Hospital, Connecticut Children,s Medical Center, ...
... Ariz., Nov. 10 A recent national survey of 505 ... is important for a patient to seek treatment early to ... And 75 percent of pharmacists say most patients should purchase ... of symptoms, while only 26 percent of their patients take ...
Cached Medicine Technology:Jefferson Radiology Acquires Two Medical Imaging Center Offices 2Pharmacists Report Patients do not Treat Cold and Flu Symptoms Early Enough, New Survey Shows 2Pharmacists Report Patients do not Treat Cold and Flu Symptoms Early Enough, New Survey Shows 3
(Date:4/28/2015)... Diego, CA (PRWEB) April 28, 2015 ... 1000 members sign up for their newly launched L-Style ... over 10,000 pounds and counting in just two short ... a tailored diet and exercise plan for men and ... and achieve their weight loss and weight maintenance goals ...
(Date:4/28/2015)... Tools4ever, the market leader in identity ... they have been chosen by IT Central Station ... Access Management vendors. IT Central Station compiled over ... Management tools by real users in 2014 and ... trends to come up with the top ten ...
(Date:4/28/2015)... City, Missouri (PRWEB) April 28, 2015 ... exclusively to healthcare executive search, announced today that it ... President & Chief Operating Officer search for ... . , Reporting to QHS President & CEO ... Operating Officer will have operating responsibility for the Queen’s ...
(Date:4/28/2015)... 28, 2015 Brain: The Inside Story, ... of Natural History, will open at the Museum at ... sponsorship from Saint Luke’s Health System. Coming to Kansas ... Granada and Milan, this one-of-a-kind exhibition brings neuroscience to ... , “Saint Luke’s and Museum at Prairiefire share ...
(Date:4/28/2015)... 28, 2015 An Allegheny Health ... Jobe, MD, FACS , has launched the first U.S. ... extracellular matrix (ECM) can help patients who are at ... cancer. , ECM is a complex mixture of naturally-occurring ... migration and signals that guide cell behavior. ECM, manufactured ...
Breaking Medicine News(10 mins):Health News:Sports Nutrition Supplement Brand, Liporidex, Is Making History With Its New L-Style Revolution Diet & Exercise Program Reaching Over 10,000 Pounds Lost In Two Months 2Health News:Sports Nutrition Supplement Brand, Liporidex, Is Making History With Its New L-Style Revolution Diet & Exercise Program Reaching Over 10,000 Pounds Lost In Two Months 3Health News:Tools4ever Chosen as Part of “Top Identity and Access Management Tools - 2015 Edition” 2Health News:The Queen’s Health Systems Retains MSA Executive Search to Recruit Executive Vice President & Chief Operating Officer 2Health News:Saint Luke's Health System to sponsor Brain: The Inside Story exhibition at Museum at Prairiefire 2Health News:Allegheny Health Network Launches First U.S. Clinical Trial of Extracellular Matrix as Replacement for Pre-Cancerous Tissue 2Health News:Allegheny Health Network Launches First U.S. Clinical Trial of Extracellular Matrix as Replacement for Pre-Cancerous Tissue 3
... hold clues to blood, bladder and ovarian malignancies, researchers ... close look at a tumor,s or patient,s genetics can ... cancer. , So say scientists who outlined their research ... Cancer Research,s annual meeting, in Denver. , "This is ...
... 22 TOPICA Pharmaceuticals today announced the enrollment of ... for the treatment of tinea pedis (athlete,s foot). ... of the most potent and broad spectrum molecules in ... potential to provide physicians and patients with a needed ...
... will host its annual investor and analyst day on Thursday, May 14th from ... for the meeting includes:, , ... Plasma Market Trends , Blood ... , , , , The meeting is ...
... 22 It,s not every day people have the opportunity ... time. From April 1 through June 30, 2009, however, The ... to do just that.A durable plastic card the size of ... The ICEcard, lists a person,s full name, age, address and ...
... Highlight Data for its Two Newest Urological Products -CORONA, ... WPI ), a global leader in the development ... host and webcast a meeting for the investment community ... place in Chicago, Illinois, April 25-30, 2009. The company ...
... patients were the first in the area to benefitPALO ... their 70s, have become the first people in Allentown, ... of radiotherapy for cancer. A 72-year-old man was treated ... for a brain tumor at the base of her ...
Cached Medicine News:Health News:Gene Studies Reveal Cancer's Secrets 2Health News:Gene Studies Reveal Cancer's Secrets 3Health News:Gene Studies Reveal Cancer's Secrets 4Health News:Gene Studies Reveal Cancer's Secrets 5Health News:TOPICA Begins Phase 2 Clinical Trial of Potent Antifungal, Luliconazole, in Athlete's Foot 2Health News:TOPICA Begins Phase 2 Clinical Trial of Potent Antifungal, Luliconazole, in Athlete's Foot 3Health News:Haemonetics Sets Date for Investor/Analyst Meeting 2Health News:The ICEcard Combines Peace of Mind and Social Responsibility in One Handy Card: Families Prepare for Emergencies While Supporting Worthy Causes 2Health News:Watson to Host and Webcast Investment Community Meeting at American Urological Association Annual Meeting 2Health News:Watson to Host and Webcast Investment Community Meeting at American Urological Association Annual Meeting 3Health News:RapidArc Radiotherapy Technology Enabling Fast, Accurate Treatments for Pennsylvania Cancer Patients 2Health News:RapidArc Radiotherapy Technology Enabling Fast, Accurate Treatments for Pennsylvania Cancer Patients 3
... seamless eliminating the possibility of leakage around glued ... temperature resistant gel trays meaning you do no ... added user friendliness, the Primo tanks come with ... The Primo Gel Systems are designed to be ...
... up and safe to use, the Gel XL ... and running agarose gels. The unit is compact, ... power supply eliminates a tangled mess of leads ... Designed for safety and convenience, the power supply ...
... HE 33 Mini Submarine Unit for nucleic acid analysis ... designed for very fast separations of DNA restriction fragments ... a heat-sink. Fill the base with coolant and seal. ... keeping the unit in a freezer or by immersing ...
... 2000 apparatus and ready-to-use gels are the ... of nucleic acids by submerged gel electrophoresis. ... system, offering full compatibility and optimal performance, ... SEA 2000 and a unique staining tray, ...
Medicine Products: